Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology
- PMID: 21115958
- PMCID: PMC3014235
- DOI: 10.1212/WNL.0b013e3181ff96dd
Quality improvement in neurology: AAN Parkinson disease quality measures: report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology
Abstract
Background: Measuring the quality of health care is a fundamental step toward improving health care and is increasingly used in pay-for-performance initiatives and maintenance of certification requirements. Measure development to date has focused on primary care and common conditions such as diabetes; thus, the number of measures that apply to neurologic care is limited. The American Academy of Neurology (AAN) identified the need for neurologists to develop measures of neurologic care and to establish a process to accomplish this.
Objective: To adapt and test the feasibility of a process for independent development by the AAN of measures for neurologic conditions for national measurement programs.
Methods: A process that has been used nationally for measure development was adapted for use by the AAN. Topics for measure development are chosen based upon national priorities, available evidence base from a systematic literature search, gaps in care, and the potential impact for quality improvement. A panel composed of subject matter and measure development methodology experts oversees the development of the measures. Recommendation statements and their corresponding level of evidence are reviewed and considered for development into draft candidate measures. The candidate measures are refined by the expert panel during a 30-day public comment period and by review by the American Medical Association for Current Procedural Terminology (CPT) II codes. All final AAN measures are approved by the AAN Board of Directors.
Results: Parkinson disease (PD) was chosen for measure development. A review of the medical literature identified 258 relevant recommendation statements. A 28-member panel approved 10 quality measures for PD that included full specifications and CPT II codes.
Conclusion: The AAN has adapted a measure development process that is suitable for national measurement programs and has demonstrated its capability to independently develop quality measures.
Comment in
-
Quality improvement in neurology: AAN Parkinson disease quality measures.Neurology. 2011 Jul 26;77(4):406; author reply 406. doi: 10.1212/WNL.0b013e3182246fb2. Neurology. 2011. PMID: 21788621 No abstract available.
Similar articles
-
Quality improvement in neurology: AAN epilepsy quality measures: Report of the Quality Measurement and Reporting Subcommittee of the American Academy of Neurology.Neurology. 2011 Jan 4;76(1):94-9. doi: 10.1212/WNL.0b013e318203e9d1. Neurology. 2011. PMID: 21205698
-
Practice improvement requires more than guidelines and quality measures.Neurology. 2016 Jan 12;86(2):188-93. doi: 10.1212/WNL.0000000000002116. Epub 2015 Oct 30. Neurology. 2016. PMID: 26519541 Review.
-
Quality improvement in neurology: dementia management quality measures.J Am Geriatr Soc. 2014 Mar;62(3):558-61. doi: 10.1111/jgs.12630. Epub 2014 Jan 7. J Am Geriatr Soc. 2014. PMID: 24397784 Review.
-
Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines.Neurology. 2008 Jul 1;71(1):57-63. doi: 10.1212/01.wnl.0000316319.19159.c3. Neurology. 2008. PMID: 18591506
-
Quality improvement in neurology: AAN Parkinson disease quality measures.Neurology. 2011 Jul 26;77(4):406; author reply 406. doi: 10.1212/WNL.0b013e3182246fb2. Neurology. 2011. PMID: 21788621 No abstract available.
Cited by
-
miR-218-5p and miR-320a-5p as Biomarkers for Brain Disorders: Focus on the Major Depressive Disorder and Parkinson's Disease.Mol Neurobiol. 2023 Oct;60(10):5642-5654. doi: 10.1007/s12035-023-03391-y. Epub 2023 Jun 17. Mol Neurobiol. 2023. PMID: 37329382
-
Use of Figurative Language by People With Parkinson Disease to Describe "Off" Periods: Clear as Mud.Neurol Clin Pract. 2021 Aug;11(4):e462-e471. doi: 10.1212/CPJ.0000000000001059. Neurol Clin Pract. 2021. PMID: 34476127 Free PMC article.
-
Evidence for Early and Regular Physical Therapy and Exercise in Parkinson's Disease.Semin Neurol. 2021 Apr;41(2):189-205. doi: 10.1055/s-0041-1725133. Epub 2021 Mar 19. Semin Neurol. 2021. PMID: 33742432 Free PMC article. Review.
-
Characteristics of Parkinson's Disease in Patients with and without Cognitive Impairment.J Parkinsons Dis. 2021;11(3):1381-1392. doi: 10.3233/JPD-202190. J Parkinsons Dis. 2021. PMID: 33720850 Free PMC article.
-
Stakeholder perceptions of components of a Parkinson disease care management intervention, care coordination for health promotion and activities in Parkinson's disease (CHAPS).BMC Neurol. 2020 Dec 2;20(1):437. doi: 10.1186/s12883-020-02011-9. BMC Neurol. 2020. PMID: 33267827 Free PMC article. Clinical Trial.
References
-
- Lee TH. Eulogy for a quality measure. N Engl J Med 2007;357:1175–1177. - PubMed
-
- Harman JS, Scholle SH, Ng JH, et al. Association of Health Plans' Healthcare Effectiveness Data and Information Set (HEDIS) performance with outcomes of enrollees with diabetes. Med Care 2010;48:217–223. - PubMed
-
- Chassin MR, Loeb JM, Schmaltz SP, Wachter RM. Accountability measures: using measurement to promote quality improvement. N Engl J Med 2010;363:68–688. - PubMed
-
- Roland M, Campbell S, Bailey N, Whalley D, Sibbald B. Financial incentives to improve the quality of primary care in the U.K.: predicting the consequences of change. Prim Health Care Res Dev 2006;7:18–26.
-
- Centers for Medicare and Medicaid Services. Overview: Physician Quality Reporting Initiative. Available at: http://www.coms.gov/pqri/01_overview.asp? Accessed May 3, 2010.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical